Imperagen

Imperagen is a biotechnology company developing an automated enzyme engineering platform that combines AI-powered protein design with synthetic biology and laboratory automation.

The company engineers optimised biocatalysts for pharmaceutical manufacturing, enabling greener and more efficient production of complex drug molecules.

Longer-term applications span laboratory tools, enzyme replacement therapies, and sustainable fine chemical production.

Imperagen was spun out of the University of Manchester and is backed by IQ Capital and Northern Gritstone.